IL-32 Levels in Patients With Chronic Periodontitis
IL-32 Levels in Gingival Crevicular Fluid and Saliva of Patients With Chronic Periodontitis After Periodontal Treatment.
1 other identifier
interventional
54
0 countries
N/A
Brief Summary
Interleukin-32 (IL-32) is a recently described cytokine that is a strong inducer of pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α. A previous report have reported that Porphyromonas gingivalis-derived LPS significantly up-regulated IL-32 expression compared with the unstimulated cells in monocytes (THP-1 cells). They suggested that IL-32 may contribute to the pathogenesis of periodontal disease. In the present study the investigators hypothesized that IL-32 levels may increase in the gingival crevicular fluid (GCF) and saliva of patients with chronic periodontitis compared with healthy controls and these levels may decrease together with treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jul 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 10, 2015
CompletedFirst Posted
Study publicly available on registry
December 17, 2015
CompletedDecember 17, 2015
December 1, 2015
10 months
December 10, 2015
December 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemical parameters (IL-32, IL-10 and THF-alpha)
The changes in levels of IL-32 after periodontal treatment determined by ELISA. The changes in levels of IL-32 were analyzed to determine diagnostic and prognostic potential as a biomarker of periodontitis.
Baseline and 1 month after treatment
Secondary Outcomes (5)
Probing pocket depth
Baseline and 1 month after treatment
Probing pocket depth and clinical attachment level
Baseline and 1 month after treatment
Gingival index
Baseline and 1 month after treatment
Plaque index
Baseline and 1 month after treatment
Bleeding on probing
Baseline and 1 month after treatment
Study Arms (2)
chronic periodontitis patients
ACTIVE COMPARATORgingival crevicular fluid and saliva collecion were taken before and after nonsurgical periodontal treatment
periodontally healthy controls
PLACEBO COMPARATORgingival crevicular fluid and saliva collection were taken at baseline after oral hygiene instructions
Interventions
Scaling and root planning under local anaesthesia, in a total of four clinical visits Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.
GCF collection with filter paper (Periopaper) using the intracrevicular method. Patients' mouths were rinsed with distilled water, and unstimulated salivary samples were collected by patients expectorating into disposable tubes.
Eligibility Criteria
You may qualify if:
- all subjects in the study were possess of at least 20 teeth excluding third molars.
You may not qualify if:
- agressive periodontitis,
- periapical pathologies,
- excessive forces including mechanical forces caused by orthodontic forces and occlusal forces;
- presence of systemic diseases;
- administration of non-steroidal and anti-inflammatory drugs or antibiotic therapies within the previous 6 months;
- need for antibiotic prophylaxis for dental treatment and having received non-surgical periodontal treatment within the past 6 months or surgical periodontal treatment within the past 12 months;
- allergy or sensitivity to any drug,
- pregnancy,
- lactation, and
- current and former use of tobacco.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Bülent Ecevit University Faculty of Dentistry
Study Record Dates
First Submitted
December 10, 2015
First Posted
December 17, 2015
Study Start
July 1, 2014
Primary Completion
May 1, 2015
Study Completion
July 1, 2015
Last Updated
December 17, 2015
Record last verified: 2015-12